0001179110-12-014935.txt : 20121005 0001179110-12-014935.hdr.sgml : 20121005 20121005130028 ACCESSION NUMBER: 0001179110-12-014935 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20121003 FILED AS OF DATE: 20121005 DATE AS OF CHANGE: 20121005 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MILLIGAN JOHN F CENTRAL INDEX KEY: 0001191589 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19731 FILM NUMBER: 121131681 MAIL ADDRESS: STREET 1: 333 LAKESIDE DRIVE CITY: FOSTER CITY STATE: CA ZIP: 94404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GILEAD SCIENCES INC CENTRAL INDEX KEY: 0000882095 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943047598 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 6505743000 MAIL ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 4 1 edgar.xml FORM 4 - X0306 4 2012-10-03 0 0000882095 GILEAD SCIENCES INC GILD 0001191589 MILLIGAN JOHN F GILEAD SCIENCES, INC. 333 LAKESIDE DRIVE FOSTER CITY CA 94404 0 1 0 0 President and COO Common Stock 2012-10-03 4 M 0 70000 17.4975 A 329007 D Common Stock 2012-10-03 4 S 0 70000 69.8463 D 259007 D Non-Qualified Stock Option (right to buy) 17.4975 2012-10-03 4 M 0 70000 0.00 D 2013-07-29 Common Stock 70000 70000 D The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested. The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan established by Dr. Milligan on May 25, 2012 Sale prices reported for the transactions reported here range from $69.67 to $69.99. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. /s/ John F. Milligan 2012-10-05